Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virus

6-Methoxypurine arabinoside (ara-M) exhibits potent activity against varicella-zoster virus (VZV) as a result of ara-M's anabolism to the triphosphate of adenine arabinoside (ara-ATP) in VZV-infected cells. The adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) enhanced the formation of ara-ATP by inhibiting ara-M demethoxylation. In contrast, deoxycoformycin and coformycin, inhibitors of both adenosine deaminase and AMP deaminase, blocked the formation of ara-ATP and reversed the anti-VZV activity of ara-M. These results indicate that after the initial phosphorylation of ara-M by the VZV-coded thymidine kinase, the monophosphate is demethoxylated by AMP deaminase to form ara-IMP, which is converted to ara-ATP by the sequential actions of the cellular adenylosuccinate synthetase, adenylosuccinate lyase, and nucleotide kinases.

[1]  T. Burnette,et al.  Selective anabolism of 6-methoxypurine arabinoside in varicella-zoster virus-infected cells , 1991, Antimicrobial Agents and Chemotherapy.

[2]  P. de Miranda,et al.  Metabolic disposition and pharmacokinetics of the antiviral agent 6-methoxypurine arabinoside in rats and monkeys , 1991, Antimicrobial Agents and Chemotherapy.

[3]  B. Grace,et al.  6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus , 1991, Antimicrobial Agents and Chemotherapy.

[4]  S. Broder,et al.  Initial studies on the cellular pharmacology of 2',3'-dideoxyinosine, an inhibitor of HIV infectivity. , 1987, Biochemical pharmacology.

[5]  Carl Frieden,et al.  Adenosine deaminase and adenylate deaminase: comparative kinetic studies with transition state and ground state analogue inhibitors. , 1980, Biochemistry.

[6]  D. Ives,et al.  [43] Deoxycytidine kinase from calf thymus , 1978 .

[7]  T. Deuel,et al.  AMP deaminase from human erythrocytes. , 1978, Methods in enzymology.

[8]  D. Hunting,et al.  Specificity of adenosine deaminase inhibitors. , 1977, Biochemical pharmacology.

[9]  T. Spector.  Mammalian adenylosuccinate lyase. Participation in the conversion of 2'-dIMP and beta-D-arabinosyl-IMP to adenine nucleotides. , 1977, Biochimica et biophysica acta.

[10]  R. Parks,et al.  Potent inhibition of muscle 5'-AMP deaminase by the nucleoside antibiotics coformycin and deoxycoformycin. , 1977, Biochemical pharmacology.

[11]  R. Miller,et al.  Mammalian adenylosuccinate synthetase. Nucleotide monophosphate substrates and inhibitors. , 1976, Biochimica et biophysica acta.

[12]  Y. Cheng,et al.  Deoxythymidine kinase induced in HeLa TK- cells by herpes simplex virus type I and type II. II. Purification and characterization. , 1976, The Journal of biological chemistry.

[13]  H. Schaeffer,et al.  Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines. , 1974, Journal of medicinal chemistry.

[14]  J. F. Henderson,et al.  Adenosine formation and metabolism during adenosine triphosphate catabolism in Ehrlich ascites tumor cells. , 1973, Cancer research.

[15]  G. Crabtree,et al.  Pathways of purine ribonucleotide catabolism in Ehrlich ascites tumor cells in vitro. , 1971, Canadian journal of biochemistry.

[16]  Tetsuya Kato,et al.  Studies of Phosphorylation. III. Selective Phosphorylation of Unprotected Nucleosides , 1969 .

[17]  E. Kun.  Enzyme Inhibitors , 1967, Nature.

[18]  D. Hoard,et al.  CONVERSION OF MONO- AND OLIGODEOXYRIBONUCLEOTIDES TO 5-TRIPHOSPHATES. , 1965, Journal of the American Chemical Society.

[19]  C. N. Gordon,et al.  The mechanism of action of hadacidin. , 1962, The Journal of biological chemistry.

[20]  C. N. Gordon,et al.  Hadacidin, a new inhibitor of purine biosynthesis. , 1962, The Journal of biological chemistry.